Investor profile
Genghis Lloyd-Harris
Accelerator, Corporate VC, Operator-led, Venture capital & Senior Advisor at Abingworth, Reviewer at HMS MEDscience, Investor-In-Residence at Cancer Research Horizons
Genghis Lloyd-Harris works as a Senior Advisor at Abingworth. The firm's known portfolio counts 13 companies.
Is Genghis Lloyd-Harris a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
Contacts
Affiliated funds' portfolios
Senior Advisor at Abingworth, whose known portfolio counts 13 companies
- Iambic
- Glycomine
- AdvanCell
- Atsena Therapeutics
- Solve Therapeutics
- Addition Therapeutics
- Vaxcyte
- Wugen
- Pathalys Pharma
- R1 Therapeutics
- Antares Therapeutics
- Myricx Bio
- and 1 more
Reviewer at HMS MEDscience, whose known portfolio counts 2 companies
- Marvin AI
- Sherbit
Investor-In-Residence at Cancer Research Horizons, whose known portfolio counts 8 companies
- AiM Medical Robotics
- Infinitopes
- Laigo Bio
- Trogenix
- 52 North Health
- Myricx Bio
- Neobe Therapeutics
- Verinnogen
Investor Profile
Founders in the listed sectors AI, Education, Hardware and Healthcare, and focus areas Biologics, Biotech, Clinical Trials and Diagnostics fall inside that listing.
Abingworth appears in Growth, Pre-Seed and Seed rounds across its known deals.
The firm portfolio and the focus above give founders context on whether Genghis Lloyd-Harris matches their raise.
Colleagues
Showing 20 of 25
Halle Tecco
Adjunct Faculty / Course Director
London, United Kingdom
George Church
Professor
Boston, United States
Erika Pabo
Faculty
Boston, United States
Raju Kucherlapati
Professor
Weston, United States
Diya Malhotra
Principal
London, United Kingdom
Kurt von Emster
Managing Partner
Menlo Park, United States
Tim Haines
Managing Director
London, United Kingdom
Jeffrey Leerink
Board of Fellows
Boston, United States
David Walt
Hansjörg Wyss Professor of Biologically Inspired Engineering
Boston, United States
Jonathan Tobin
Investor-in-Residence
London, United Kingdom
Mason Freeman
Investor
Boston, United States
Bali Muralidhar
Global Head of Life Sciences
London, United Kingdom
Iñaki Arango
Investor
Cambridge, United States
Joan Brugge
Investor
Boston, United States
Gary Gottlieb
Professor Of Psychiatry
Boston, United States
G. Scott Gazelle
Professor of Radiology
Boston, United States
Greg Erman
Investor
Boston, United States
Vin Miles
Executive Director
Boston, United States
Jayson Punwani
Managing Director
Menlo Park, United States
Andrew Sinclair
Managing Director
Royal Tunbridge Wells, United Kingdom
Frequently asked questions
Who is Genghis Lloyd-Harris?
Genghis Lloyd-Harris is an accelerator partner and corporate venture investor based in London, England, United Kingdom, listed as Senior Advisor at Abingworth. The known portfolio of that firm counts 13 companies. That portfolio belongs to the firm, not to Genghis Lloyd-Harris personally.
What does Genghis Lloyd-Harris invest in?
Listed sectors include AI, Education, Hardware and Healthcare; listed focus areas include Biologics, Biotech, Clinical Trials and Diagnostics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Genghis Lloyd-Harris invest at?
Abingworth appears in Growth, Pre-Seed and Seed rounds across its known deals, and Genghis Lloyd-Harris is listed there as Senior Advisor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Genghis Lloyd-Harris listed at?
Genghis Lloyd-Harris is listed as Senior Advisor at Abingworth. 25 other people in the database share a firm with Genghis Lloyd-Harris.
How do I contact Genghis Lloyd-Harris?
An email address, a phone number and a LinkedIn page are on file for Genghis Lloyd-Harris. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal